اکثر مکاتبات کومش از طریق ایمیل سایت می باشد. لطفا Spam ایمیل خود را نیز چک نمایید.
   [Home ] [Archive]   [ فارسی ]  
:: ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
Subscription::
Contact us::
Site Facilities::
Webmail::
Editorial Board::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 25, Issue 5 (Sep and Oct 2023 2023) ::
Koomesh 2023, 25(5): 250-250 Back to browse issues page
A practical guide for using Streptozotocin in the induction of diabetes in rats
Asghar Ghasemi , Sajad Jeddi
Abstract:   (307 Views)
Introduction: Streptozotocin (STZ) is the most used diabetogenic chemical for creating rat models of type 1 and type 2 diabetes. Despite ~60 years of using STZ in animal diabetes research, some prevailing views about STZ preparation and use are not supported by evidence. Here, we provide practical guides for using STZ to induce diabetes in rats.
Search Method: Related articles from PubMed, Scopus, and Google Scholar from 1963, when the diabetogenic effect of STZ was first discovered, were collected and used.
Results: Susceptibility to the diabetogenic effect of STZ is inversely related to age, and males are more susceptible to STZ than females. STZ is mostly injected intravenously or intraperitoneally, but its intravenous injection produces more stable hyperglycemia. Despite the prevailing view, no fasting is necessary before STZ injection, and injection of its anomer-equilibrated solutions (i.e., about 2 hours after dissolving) is recommended. Mortality following the injection of diabetogenic doses of STZ is due to severe hypoglycemia (during the first 24 h) or severe hyperglycemia (24 h after the injection and onwards). Some measures to prevent hypoglycemia-related mortality in rats include (1) providing access to food soon after the injection, (2) administration of glucose/sucrose solutions during the first 24-48 h after the injection, (3) administration of STZ to fed animals, and (4) using anomer-equilibrated solutions of STZ. Hyperglycemia-related mortality can be overcome with insulin administration.
Conclusion: Some prevailing views on the preparation and use of STZ are not supported by evidence. For STZ administration, the age and sex of the animal, as well as the administration route and time of preparing of STZ solution, should be considered.

 
Keywords: Animal model, Rat, Streptozotocin, Diabetes
Full-Text [PDF 249 kb]   (40 Downloads)    
Type of Study: Research | Subject: General
Received: 2023/12/27 | Accepted: 2023/08/23 | Published: 2023/08/23
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ghasemi A, Jeddi S. A practical guide for using Streptozotocin in the induction of diabetes in rats. Koomesh 2023; 25 (5) :250-250
URL: http://koomeshjournal.semums.ac.ir/article-1-8392-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 25, Issue 5 (Sep and Oct 2023 2023) Back to browse issues page
کومش Koomesh
Persian site map - English site map - Created in 0.06 seconds with 38 queries by YEKTAWEB 4645